You just read:

Egalet Announces FDA Advisory Committees Recommend Approval of Abuse-Deterrent ARYMO™ ER (Morphine Sulfate) and Reports Second Quarter 2016 Financial Results

News provided by

Egalet Corporation

Aug 04, 2016, 16:47 ET